Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer

Genes Chromosomes and Cancer

Volumn 20, Issue 4, 1997, Pages 383-391

  Mahlamäki, Eija H ^a   Höglund, Mattias ^b   Gorunova, Ludmila ^b   Karhu, Ritva ^a   Dawiskiba, Sigmund ^b   Andrén Sandberg, Åke ^b   Kallioniemi, Olli P ^c   Johansson, Bertil ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYBRIDIZATION; MALE; PANCREAS CANCER; PRIORITY JOURNAL;

AGED; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; FLUORESCENT DYES; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; METAPHASE; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0343811679     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199712)20:4<383::AID-GCC10>3.0.CO;2-O     Document Type: Article

References (44)

1. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F, Heim S (1993) Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 67:1106-1112.
2. Bardi G, Åman P, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Björkman A, Sjögren HO, Andrén-Sandberg Å, Mitelman F, Heim S (1994) Cytogenetic characterization of a periampullary adenocarcinoma of the pancreas, its liver metastasis, and a cell line established from the metastasis in a patient with Gardner's syndrome. Cancer Genet Cytogenet 76:29-32.
3. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32.
4. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK, Testa JR (1996) Amplification of AKT2 in human pancreatic cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93:3636-3641.
5. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996) Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
6. Delmer A, Ajchenbaum-Cymbalista F, Tang R, Ramond S, Faussat A-M, Marie J-P, Zittoun R (1995) Overexpression of cyclin D2 in chronic B-cell malignancies. Blood 85:2870-2876.
7. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552.
8. Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, Kobari M, Horii A (1997) Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 19:161-169.
9. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE (1996) Germline BRCA2 mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56:5360-5364.
10. Gorunova L, Johansson B, Dawiskiba S, Andrén-Sandberg Å, Jin Y, Mandahl N, Heim S, Mitelman F (1995) Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty-four karyotypically unrelated clones. Genes Chromosomes Cancer 14:259-266.
11. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F, Yeo CJ (1994) Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 9:93-100.
12. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ (1995) Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 55:2394-2399.
13. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
14. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ. Hruban RH, Kern SE (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
15. Han H-J, Yanagisawa A, Kato Y, Park J-G, Nakamura Y (1993) Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53:5087-5089.
16. Höglund M, Johansson B, Pedersen-Bjergaard J, Marynen P, Mitelman F (1996) Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 87:324-330.
17. Höglund M, Gorunova L, Andrén-Sandberg Å, Dawiskiba S, Mitelman F, Johansson B (1997) Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer (in press).
18. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL (1993) K-ras oncogenc activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143:545-554.
19. Johansson B, Bardi G, Heim S, Mandahl N, Mertens F, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F (1992) Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer 69:1674-1681.
20. Johansson B, Bardi G, Pandis N, Gorunova L, Bäckman PL, Mandahl N, Dawiskiba S, Andrén-Sandberg Å, Heim S, Mitelman F (1994) Karyotypic pattern of pancreatic adenocarcinomas correlates with survival and tumour grade. Int J Cancer 58:8-13.
21. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994a) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
22. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994b) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Nad Acad Sci USA 91:2156-2160.
23. Kimura M, Abe T, Sunamura M, Matsuno S, Horii A (1996) Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1-cM region of common allelic loss. Genes Chromosomes Cancer 17:88-93.
24. Kuukasjärvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi O-P, Isola J (1997) Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57:1597-1604.
25. Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N, on behalf of the United Kingdom Children's Cancer Study Group (1997) Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer 18: 162-169.
26. Lothe RA, Karhu R, Mandahl N, Mertens F, Sæter G, Heim S, Børresen-Dale A-L, Kallioniemi O-P (1996) Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 56:4778-4781.
27. Mertens F, Johansson B, Höglund M, Mitelman F (1997) Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res (57:2765-2780).
28. Mitelman F, Mertens F, Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417-474.
29. Miwa W, Yasuda J, Murakami Y, Yashima K, Sugano K, Sekine T, Kono A, Egawa S, Yamaguchi K, Hayashizaki Y, Sekiya T (1996) Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer. Biochem Biophys Res Commun 225:968-974.
30. Murr MM, Sarr MG, Oishi AJ, van Heerden JA (1994) Pancreatic cancer. CA Cancer J Clin 44:304-318.
31. Ohta M, Inoue H, Cotticelli MH, Kastury K, Baffa R, Palazzo J, Siprashivili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
32. Panagopoulos I, Thelin S, Mertens F, Mitelman F, Åman P (1997) Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer 19:215-219.
33. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Yogelstein B (1996) Mad-related genes in the human. Nat Genet 13:347-349.
34. Ruggeri B, Zhang S-Y, Caamano J, DiRado M, Flynn SD, Klein-Szanto AJP (1992) Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7:1503-1511.
35. Sakorafas GH, Lazaris A, Tsiotou AG, Koullias G, Glinatsis MT, Golematis BC (1995) Oncogenes in cancer of the pancreas. Eur J Surg Oncol 21:251-253.
36. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes: A review. Gene 159:83-96.
37. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE (1994) Allelotype of pancreatic adenocarcinoma. Cancer Res 54:2761-2764.
38. Shridhar R, Shridhar V, Wang X, Paradee W, Dugan M, Sarkar F, Wilke C, Glover TW, Vaitkevicius VK, Smith DI (1996) Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. Cancer Res 56:4347-4350.
39. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA (1996) Cydin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474.
40. Silverman JA, Kuhlmann ET, Zurlo J, Yager JD, Longnecker DS (1990) Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats. Mol Carcinog 3:379-386.
41. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P (1996) Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807.
42. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjärvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi O-P (1996) Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
43. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T (1996) Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers Cancer Res 56:5583-5585.
44. Yamada H, Sakamoto H, Taira M, Nishimura S, Shimosato Y, Terada M, Sugimura T (1986) Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. Jpn J Cancer Res (Gann) 77:370-375.